Development of diffuse invasive (grade 4D) human oral squamous cell carcinoma model in severe combined immunodeficiency mice: Microangioarchitectural analysis and immunohistochemical study

Oral Oncology

Volumn 35, Issue 4, 1999, Pages 395-400

  Moriyama, M ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

Human oral squamous cell carcinoma; Human OSCC; Immunohistochemical study; Mode of invasion; Orthotopic implantation; SCID mice

Indexed keywords

COLLAGEN TYPE 4; DESMOGLEIN; GELATINASE A; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER INVASION; CARCINOGENICITY; COMBINED IMMUNODEFICIENCY; FEMALE; IMMUNOHISTOCHEMISTRY; MOUSE; MOUTH CARCINOMA; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA;

ANIMALS; CARCINOMA, SQUAMOUS CELL; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, SCID; MOUTH NEOPLASMS; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; TUMOR CELLS, CULTURED;

EID: 0033168354     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1368-8375(99)00009-3     Document Type: Article

References (25)

1. Yamamoto E., Kohama G.-I., Sunakawa H., Iwai M., Hiratsuka H. Mode of invasion, bleomysin sensitivity, and clinical course in squamous cell carcinoma of the oral cavity. Cancer. 51:1983;2175-2180.
2. Yamamoto E., Miyakawa A., Kohama G.-I. Mode of invasion and lymph node metastasis in squamous cell carcinoma of the oral cavity. Head and Neck Surgery. 6:1984;938-947.
3. Yokoi T., Hirata S., Nishimura F.et al. Some properties of a newly established human cell line derived from an oral squamous carcinoma. Tumor Research. 25:1990;93-103.
4. Yokoi T., Yamaguchi A., Odajima T., Furukawa K. Establishment and characterization of a human cell line derived from a squamous cell carcinoma of the tongue. Tumor Research. 23:1988;43-57.
5. Kawashiri S., Kumagai S., Kojima K., Harada H., Yamamoto E. Development of a new invasion and metastasis model of human oral squamous cell carcinomas. Oral Oncology. 31B(4):1995;216-221.
6. Hayashi E., Rikimaru K., Nagayama M. Simultaneous production of G- and M-CSF by an oral cancer cell line and the synergistic effects on associated leucocytosis. Oral Oncology. 31B(5):1995;323-327.
7. Moriyama M., Kumagai S., Kawashiri S., Harada H., Kakihara K.-I., Yamamoto E. Reproduction of grade 4D invasive growth of human oral squamous cell carcinoma in nude mice. Japanese Journal of Tissue Culture Society for Dental Research 1998; 7(1):33-8 (in Japanese with English abstract).
8. Fridman R., Giaccone G., Kanemoto T., Martin G.R., Gazdar A.F., Mulshine J.L. Reconstituted basement membrane (matrigel) and laminin can enhance the tumorigenicity and the drug resistance of small cell lung cancer cell lines. Proceedings of the National Academy of Science USA. 87:1990;6698-6702.
9. Bao L., Matsumura Y., Baban D., Sun Y., Tarin D. Effects of inoculation site and matrigel on growth and metastasis of human breast cancer cells. British Journal of Cancer. 70:1994;228-232.
10. Bonfil R.D., Vinyals A., Bustuoabad O.D.et al. Stimulation of angiogenesis as an explanation of matrigel-enhanced tumorigenicity. International Journal of Cancer. 58:1994;233-239.
11. Okada F., Hosokawa M., Hamada J.-I.et al. Malignant progression of a mouse fibrosarcoma by host cells reactive to a foreign body (gelatin sponge). British Journal of Cancer. 66:1992;635-639.
12. Ruoslahti E., Reed J.C. Anchorage dependence, integrins, and apoptosis. Cell. 77:1994;477-478.
13. Frisch S.M., Francis H. Disruption of epithelial cell-matrix interactions induces apoptosis. Journal of Cell Biology. 124:1994;619-626.
14. Bosma G.C., Cluster R.P., Bosma M.J. A severe combined immunodeficiency mutation in the mouse. Nature. 301(10):1983;527-531.
15. Folkman J. Tumor angiogenesis. Advances in Cancer Research. 43:1985;175-203.
16. Gimbrone M.A., Cotran R.S. Jr., Leapman S.B., Folkman J. Tumour growth and neovascularization: an experimental model using the rabbit cornea. Journal of National Cancer Institute. 52:1974;413-427.
17. Weidner N., Semple J.P., Welch W.R., Folkman J. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. New England Journal of Medicine. 324:1991;1-8.
18. Weidner N., Carroll P.R., Flax J., Blumenfeld W., Folkman J. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. American Journal of Pathology. 143:1993;401-409.
19. Takahashi Y., Kitadai Y., Corazon D.B., Bucana C.D., Cleary K.R., Ellis L.M. Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Research. 55:1995;3964-3968.
20. Penfold C.N., Partridge M., Rojas R., Langdon J.D. The role of angiogenesis in the spread of oral squamous cell carcinoma. British Journal of Oral and Maxillofacial Surgery. 34:1996;37-41.
21. Shibuya M. Role of VEGF-FLT receptor system in normal and tumor angiogenesis. Advances in Cancer Research. 67:1995;281-316.
22. Imai K., Kumagai S., Nakagawa K.et al. Immunolocalization of desmoglein and intermediate filaments in human oral squamous cell carcinomas. Head and Neck. 17:1995;204-212.
23. Denis L.J., Verweij J. Matrix metalloproteinase inhibitors: present achievements and future prospects. Investigational New Drugs. 15(3):1997;175-185.
24. Wojtowicz-Praga S., Torii J., Johnson M.et al. Phase I trial of Marimastat, a novel matrix metalloproteinase inhibitor, administered orally to patients with advanced lung cancer. Journal of Clinical Oncology. 16(6):1998;2150-2156.
25. Molema G., Meijer D.K., de Leij L.F. Tumor vasculature targeted therapies: getting the players organized. Biochemical Pharmacology. 55(12):1998;1939-1945.